Zelpha D'souza
Manchester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A systematic review to identify how children and young people were included in the development of pediatric core outcome sets.
Journal: Journal of clinical epidemiology
Published: March 17, 2025
Brain-targeted stem cell gene therapy corrects mucopolysaccharidosis type II via multiple mechanisms.
Journal: EMBO molecular medicine
Published: June 10, 2018
A novel adeno-associated virus capsid with enhanced neurotropism corrects a lysosomal transmembrane enzyme deficiency.
Journal: Brain : a journal of neurology
Published: November 30, 2017
Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapy.
Journal: Brain : a journal of neurology
Published: June 26, 2017
De novo DNA methylation drives 5hmC accumulation in mouse zygotes.
Journal: Nature cell biology
Published: July 21, 2015
Kcnn4 is a regulator of macrophage multinucleation in bone homeostasis and inflammatory disease.
Journal: Cell reports
Published: January 27, 2014
Experimental crescentic glomerulonephritis: a new bicongenic rat model.
Journal: Disease models & mechanisms
Published: September 19, 2013
Combined ChIP-Seq and transcriptome analysis identifies AP-1/JunD as a primary regulator of oxidative stress and IL-1β synthesis in macrophages.
Journal: BMC genomics
Published: October 13, 2012
Role of novel rat-specific Fc receptor in macrophage activation associated with crescentic glomerulonephritis.
Journal: The Journal of biological chemistry
Published: December 21, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026